Soocian
Search Results
See All Results
  • Join
    Sign In
    Sign Up
    Search
    Theme Switcher
    Night Mode

Search

Discover new people, create new connections and make new friends

  • News Feed
  • Mine
    • My Blogs
    • My Products
    • My Funding
    • My Offers
    • My Jobs
  • EXPLORE
  • Pages
  • Groups
  • Events
  • Reels
  • Blogs
  • Market
  • Funding
  • Offers
  • Jobs
  • Forums
  • Movies
  • Games
  • Posts
  • Blogs
  • Users
  • Pages
  • Groups
  • Events
  • 苏美 王 added blog Other
    2026-07-30 02:57:22 -
    Anoramic Landscape of QS-21 Adjuvant: Overview of Suppliers, Pipeline Applications and Technical Routes
    1. Introduction to QS-21 Basic Definition: QS-21 is a mixture composed of two saponin molecules, naturally present in Quillaja saponaria(commonly known as Quillay), a tree species endemic to Chile. Core Function: It is one of the most potent adjuvants currently known, capable of significantly enhancing and modulating the immune response to vaccine antigens. In most formulations,...
    0 Comments 0 Shares 322 Views 0 Reviews
    Please log in to like, share and comment!
  • 苏美 王 added blog Other
    2026-07-09 02:11:07 -
    Gentle Quillaja Adjuvant: Balancing Immune Potency and Biological Safety
    In the ever-evolving landscape of immunology and vaccine development, the quest for effective adjuvants has led to the emergence of innovative solutions that enhance immune responses. Among these, Gentle Quillaja Adjuvant stands out as a high-purity, concentrated saponin adjuvant that not only boosts immune responses but also serves as a general immune enhancer. Developed by GC...
    0 Comments 0 Shares 557 Views 0 Reviews
    Please log in to like, share and comment!
  • 苏美 王 added blog Other
    2026-06-10 07:00:37 -
    The Potential and Advantages of Using the AS01 Adjuvant in Next-Generation Adjuvanted Influenza Vaccines
    Influenza vaccines represent one of the largest segments of the global vaccine market (with the global market size exceeding $8 billion by 2025). However, the protective efficacy of traditional split-virus vaccines has long hovered between 30% and 50% among individuals aged 65 and older and immunocompromised populations. Additionally, these vaccines require annual updates, offer short-term...
    0 Comments 0 Shares 392 Views 0 Reviews
    Please log in to like, share and comment!
© 2026 Soocian English
English Arabic French Spanish Portuguese Deutsch Turkish Dutch Italiano Russian Romaian Portuguese (Brazil) Greek
About Privacy Policy Terms of Use Refund and Cancellation Policy Subscription Terms / شروط الاشتراك EU Consumer and Privacy Rights / الحقوق الأوروبية Contact Us Support Center Directory